Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Shanghai Stock Exchange  >  Jiangsu Hengrui Medicine Co., Ltd.    600276   CNE0000014W7

JIANGSU HENGRUI MEDICINE CO., LTD.

(600276)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
09/14/2020 09/15/2020 09/16/2020 09/17/2020 09/18/2020 Date
91.36 91.1 89.74 86.29 88.98 Last
15482410 14888130 19517120 42304510 29771720 Volume
-0.49% -0.28% -1.49% -3.84% +3.12% Change
Financials
Sales 2020 29 140 M 4 311 M 4 311 M
Net income 2020 6 616 M 979 M 979 M
Net cash position 2020 13 807 M 2 043 M 2 043 M
P/E ratio 2020 68,0x
Yield 2020 0,24%
Sales 2021 36 692 M 5 428 M 5 428 M
Net income 2021 8 544 M 1 264 M 1 264 M
Net cash position 2021 18 477 M 2 734 M 2 734 M
P/E ratio 2021 52,4x
Yield 2021 0,31%
Capitalization 456 B 67 413 M 67 457 M
EV / Sales 2020 15,2x
EV / Sales 2021 11,9x
Nbr of Employees 24 431
Free-Float 44,6%
More Financials
Company
Jiangsu Hengrui Medicine Co., Ltd. specializes in the research, development, manufacture and marketing of pharmaceutical products. The activity is organized primarily around 5 families of products: - anti-tumor drugs (No. 1 Chinese); - Anesthetic drugs; - contrast agents: used in medical imaging; - anti-inflammatory drugs; - drugs for the treatment of cardiovascular diseases. 
Sector
Pharmaceuticals
Calendar
10/23Earnings Release
More about the company
Notations Surperformance© of Jiangsu Hengrui Medicine Co., Ltd.
Trading Rating : Investor Rating :
More Ratings
All news about JIANGSU HENGRUI MEDICINE CO., LTD.
08/21Stymied at home, Korea's mom and pop investors charge into China tech stocks
RE
08/21Stymied at home, Korea's mom and pop investors charge into China tech stocks
RE
08/18THERMO FISHER SCIENTIFIC : Signs Companion Diagnostic Agreement with Hengrui The..
AQ
05/25JIANGSU HENGRUI MEDICINE CO., LTD. : 20% Stock Dividend
FA
05/25JIANGSU HENGRUI MEDICINE CO., LTD. : Ex-dividend day for final dividend
FA
04/27Jiangsu Hengrui Medicine 1Q Net Profit Rose 10%
DJ
04/23JIANGSU HENGRUI MEDICINE CO., LTD. : quaterly earnings release
03/23Jiangsu Hengrui 2019 Net Profit Jumped on Stronger Sales
DJ
03/18JIANGSU HENGRUI MEDICINE CO., LTD. : annual earnings release
01/21How a virus impacts the economy and markets
RE
2019JIANGSU HENGRUI MEDICINE : Mycovia Pharmaceuticals and Jiangsu Hengrui Medicine ..
BU
2019JIANGSU HENGRUI MEDICINE CO. : 20% Stock Dividend
FA
2019JIANGSU HENGRUI MEDICINE CO. : Ex-dividend day for final dividend
FA
2018JIANGSU HENGRUI MEDICINE CO LTD : BONUS ISSUE: 3 new shares for 10 existing shar..
FA
2018JIANGSU HENGRUI MEDICINE CO LTD : Ex-dividend day for final dividend
FA
More news
News in other languages on JIANGSU HENGRUI MEDICINE CO., LTD.
04/23JIANGSU HENGRUI MEDICINE CO., LTD. : Veröffentlichung des Quartalsergebnisses
04/23JIANGSU HENGRUI MEDICINE CO., LTD. : publication des résultats trimestriels
04/06VALEURS MOYENNES DU BTP : Après l'arrêt total, la reprise des chantiers reste co..
03/18JIANGSU HENGRUI MEDICINE CO., LTD. : Veröffentlichung des Jahresergebnisses
03/18JIANGSU HENGRUI MEDICINE CO., LTD. : publication des résultats annuels
More news
Chart JIANGSU HENGRUI MEDICINE CO., LTD.
Duration : Period :
Jiangsu Hengrui Medicine Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JIANGSU HENGRUI MEDICINE CO., LTD.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 25
Average target price 100,49 CNY
Last Close Price 86,29 CNY
Spread / Highest target 38,4%
Spread / Average Target 16,5%
Spread / Lowest Target -13,6%
EPS Revisions
Managers
NameTitle
Yun Shu Zhou General Manager & Director
Wei Dong Chairman-Supervisory Board
Piao Yang Sun Chairman
Song Zhou Chief Financial Officer
Xin Hua Jiang Vice Chairman
Sector and Competitors
1st jan.Capitalization (M$)
JIANGSU HENGRUI MEDICINE CO., LTD.18.31%67 413
JOHNSON & JOHNSON0.89%387 473
ROCHE HOLDING AG7.29%316 308
MERCK & CO., INC.-5.84%216 604
PFIZER, INC.-6.13%204 604
NOVARTIS AG-10.45%199 361